Overview
- 3 inspections across 3 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-10-25.
At a glance
Inspections
3
Sites
3
Observations
3
Career since
May 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Laboratorios Liconsa SAU | 25 Oct 2019 | Human Drugs | On file |
| Pfizer, Inc. | 18 Jul 2018 | Human Drugs | View 483 → |
| Alkermes, Inc | 4 May 2018 | Human Drugs |
Sites inspected
Laboratorios Liconsa SAUAzuqueca De Henares, Spain1 insp.
Pfizer, Inc.Groton, United States1 insp.
Alkermes, IncWilmington, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lata C Mathew1 shared
Chunsheng Cai1 shared
Rapti D Madurawe1 shared
Ruo H Xu1 shared
Ucheabuchi C Chudi-Nwankwor1 shared
Lindsey M Schwierjohann1 shared
Edmund F Mrak1 shared
Full investigator report
Get the verbatim findings behind Hang N Guo's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site